The product, BioReady DBM Putty, is a demineralized bone matrix implant. It is an extension of the company’s DBM portfolio, which also includes BioSet DBM Paste and BioAdapt Foam.
The putty and putty with chips are 100 percent allograft. The implants do not require preparation and are available in various sizes for bone void fillers. All products are sterilized through a combination of oxidative treatments and acid or alcohol washes, where cellular debris is removed and pathogens inactivated.
More Articles on Orthopedic & Spine Devices:
ConforMIS Names Peter Traynor CFO
Patient-Specific Implants — the Future for Orthopedics: Q&A With Dr. Greg Martin of JFK Medical Center
ConforMIS Appoints Peter Traynor CFO
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.